TNFSF12
Basic information
Region (hg38): 17:7548508-7557890
Links
Phenotypes
GenCC
Source:
- common variable immunodeficiency (Supportive), mode of inheritance: AD
- common variable immunodeficiency (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Common_variable_immunodeficiency (237 variants)
- not_provided (11 variants)
- not_specified (10 variants)
- TNFSF12-related_disorder (9 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFSF12 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003809.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 61 | 65 | ||||
missense | 116 | 117 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 0 | 0 | 124 | 62 | 4 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNFSF12 | protein_coding | protein_coding | ENST00000557233 | 11 | 12718 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.770 | 0.230 | 124514 | 0 | 15 | 124529 | 0.0000602 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.983 | 137 | 173 | 0.790 | 0.0000101 | 2068 |
Missense in Polyphen | 31 | 55.131 | 0.56229 | 612 | ||
Synonymous | -0.330 | 74 | 70.5 | 1.05 | 0.00000413 | 699 |
Loss of Function | 3.60 | 4 | 22.4 | 0.178 | 0.00000137 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000461 | 0.000460 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000607 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000269 | 0.0000269 |
Middle Eastern | 0.0000607 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to FN14 and possibly also to TNRFSF12/APO3. Weak inducer of apoptosis in some cell types. Mediates NF-kappa-B activation. Promotes angiogenesis and the proliferation of endothelial cells. Also involved in induction of inflammatory cytokines. Promotes IL8 secretion. {ECO:0000269|PubMed:10085077, ECO:0000269|PubMed:23667509}.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway;TWEAK;induction of apoptosis through dr3 and dr4/5 death receptors;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway;TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.504
Intolerance Scores
- loftool
- 0.174
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.28
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.302
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0777
Mouse Genome Informatics
- Gene name
- Tnfsf12
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- angiogenesis;positive regulation of endothelial cell proliferation;apoptotic process;immune response;signal transduction;regulation of signaling receptor activity;cell differentiation;tumor necrosis factor-mediated signaling pathway;endothelial cell migration;positive regulation of protein catabolic process;positive regulation of angiogenesis;extrinsic apoptotic signaling pathway;positive regulation of extrinsic apoptotic signaling pathway
- Cellular component
- extracellular region;extracellular space;plasma membrane;integral component of plasma membrane;perinuclear region of cytoplasm
- Molecular function
- signaling receptor binding;cytokine activity;tumor necrosis factor receptor binding;protein binding